Rising Pharma Holding, Inc. recalls buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Ph
Recalled January 17, 2024 · FDA recall D-0222-2024 · Rising Pharma Holding
Hazard
Presence of Foreign Tablets/Capsules · FDA Class II
Units
47,976 bottles
Sold at
Nationwide within the United States
Description
Presence of Foreign Tablets/Capsules
Product
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03
Manufacturer(s)
Rising Pharma Holding, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →